CD274 and B-cell chronic lymphocytic leukemia: Lymph node-residing CLL cells, which have been shown to comprise activated, proliferating tumour cells with high expression of costimulatory and adhesion molecules (Patten et al, 2008; Plander et al, 2009), would thus be protected from T cell-mediated cytolysis by expressing CD274.